Allied Market Research
Upcoming Allied Market Research
Personalized Cancer Medicine Market

Personalized Cancer Medicine Market by Product Type (Genetic Testing, DTC Diagnostics, Esoteric Lab Services, Esoteric Lab Tests, Pharmaceutical, Genomic Medicine, Medical Devices, Telemedicine, Health Information Technology, Retail Nutrition, and Complementary & Alternative Medicine), Application (Blood Cancer, Breast Cancer, Intestinal Cancer, Prostate Cancer, Respiratory/Lung cancer, Skin Cancer, Bone Cancer, and Others), Technology (Immunohistochemistry, In Situ Hybridization (ISH), Quantitative PCR, Next-generation Sequencing, and Microarray), and End User (Hospitals, Research Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Nov 2021 | 11 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Personalized Cancer Medicine Market

Request Now !

Personalized cancer medicine is the healthcare procedure of designing medical care as per individual genes and the specific disease the patient is suffering from. The procedure provides additional pros such as specific medication and less technical discrepancies. Personalized cancer medication includes screening tests to diagnose cancer, matching treatment mechanism as per specific genes, and further predict risk of reoccurrence. Examples of personalized medicine includes targeted treatment and pharmacogenomics. Targeted treatment allows attacking specific amino acids that allow the cancer cells to grow and spread in the body. Targeted treatment works on bladder cancer, brain cancer, and cervical cancer. Additionally, pharmacogenomics works towards studying genetic response toward pharmaceutical drugs. It contemplates effect of genes on the drugs administered in the body.

There are a few challenges still to be contemplated with respect to personalized cancer care. This includes unavailability of personalized treatment for all types of cancers and the higher costs associated with genetic testing.

Market Scope and Structure Analysis

Report Metric


 Market Size Available for Years


 Base Year Considered


 Forecast Period


 Forecast Unit

 Value (USD)

 Segments Covered

 Product Type, Application, Technology, End User, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Pfizer, Qiagen, Quest Diagnostics, Medtronic, Novartis, LABORATORY CORPORATION OF AMERICA HOLDINGS, bioMérieux, Abbott, Roche, Eli Lilly & Company, Glaxosmithkline Plc (GSK), Cepheid, AstraZeneca, Cancer Genetics, Thermo Fisher Scientific, Bristol-Myers Squibb Myriad Genetics and Foundation Medicine.


COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global personalized cancer treatment market.

Top Impacting Factors

  • Availability of large-scale genomic database spread across research labs and subsequent improvements in precision therapies is anticipated to drive market growth for personalized cancer treatment market.
  • New age technological improvements such as computational tools are anticipated to further drive market growth. These tools have been employed in studying DNA mechanisms and gene regulations in cancer therapy.
  • Robust investments being influx into research and development of advanced oncology coupled with growing number of skilled human resource willing to work on personalized treatment mechanisms is slated to gain significant market traction.
  • Ability of personalized cancer treatment mechanisms to deploy medications as per specific genes and underlying disorders pertaining individually in every patient is further driving the growth. This is more evident in economically advanced nations with higher purchasing power populace.
  • However, higher costs associated with design, development and deployment of personalized treatments may hamper market growth. This is witnessed more in regions with less awareness, inefficient infrastructure and less economic muscle.

Key Market Trends

  • North America is anticipated to gain significant market traction owing to increasing public health concerns regarding infectious diseases such as pneumonia. Pneumonia is known to be associated with adenovirus infection.
  • WIN, a global player in cancer therapy market recently developed a unique biomarker platform based on genomics in an attempt to significantly increase volume of patients that get access to targeted personalized therapies. The technique was successfully tested in an innovative WINTHER trial.
  • Researchers at Michigan University are working at the prospectus of deploying tumor organoids to support personalized cancer treatment market. They basically targeted several doses of tumor organoids to the actual therapies that patients received as part of cancer treatment procedure and found out that organoids responses forecasted as to when drugs would work in the patients vis-à-vis wont.
  • Researchers at Cleveland University (CU) recently developed My Personal Mutanome (MPM), a platform that features interactive dashboards that provide insights into role of disease-associated mutations in cancer.

Key Segments Covered



 Product Type

  • Genetic Testing
  • DTC Diagnostics
  • Esoteric Lab Services
  • Esoteric Lab Tests
  • Pharmaceutical
  • Genomic Medicine
  • Medical Devices
  • Telemedicine
  • Health Information Technology
  • Retail Nutrition
  • Complementary & Alternative Medicine


  • Blood cancer
  • Breast Cancer
  • Intestinal Cancer
  • Prostate Cancer
  • Respiratory/Lung cancer
  • Skin Cancer
  • Bone Cancer
  • Others


  • Immunohistochemistry
  • in situ hybridization (ISH)
  • quantitative PCR
  • next-generation sequencing
  • microarray

 End User

  • Hospitals
  • Research Laboratories
  • Others


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Benefits of the Report

  • This study presents the analytical depiction of the personalized cancer medicine industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the personalized cancer medicine market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the personalized cancer medicine growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Personalized Cancer Medicine Report

  • Which are the leading players active in the personalized cancer medicine market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the personalized cancer medicine market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is personalized cancer medicine?
  • What is the personalized cancer medicine market prediction in the future?
  • What are the current trends and predicted trends?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Personalized Cancer Medicine Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers